These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21421858)

  • 1. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
    Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
    Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of PELP1 in ER-negative breast cancer metastasis.
    Roy S; Chakravarty D; Cortez V; De Mukhopadhyay K; Bandyopadhyay A; Ahn JM; Raj GV; Tekmal RR; Sun L; Vadlamudi RK
    Mol Cancer Res; 2012 Jan; 10(1):25-33. PubMed ID: 22086908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
    Cortez V; Mann M; Tekmal S; Suzuki T; Miyata N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Vadlamudi RK
    Breast Cancer Res; 2012 Jul; 14(4):R108. PubMed ID: 22812534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells.
    Wan J; Li X
    Oncol Rep; 2012 Dec; 28(6):2035-42. PubMed ID: 22992812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.
    Roy SS; Gonugunta VK; Bandyopadhyay A; Rao MK; Goodall GJ; Sun LZ; Tekmal RR; Vadlamudi RK
    Oncogene; 2014 Jul; 33(28):3707-16. PubMed ID: 23975430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
    Chakravarty D; Nair SS; Santhamma B; Nair BC; Wang L; Bandyopadhyay A; Agyin JK; Brann D; Sun LZ; Yeh IT; Lee FY; Tekmal RR; Kumar R; Vadlamudi RK
    Cancer Res; 2010 May; 70(10):4092-101. PubMed ID: 20460518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
    Halder J; Kamat AA; Landen CN; Han LY; Lutgendorf SK; Lin YG; Merritt WM; Jennings NB; Chavez-Reyes A; Coleman RL; Gershenson DM; Schmandt R; Cole SW; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2006 Aug; 12(16):4916-24. PubMed ID: 16914580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PELP1/MNAR signaling in ovarian tumorigenesis.
    Dimple C; Nair SS; Rajhans R; Pitcheswara PR; Liu J; Balasenthil S; Le XF; Burow ME; Auersperg N; Tekmal RR; Broaddus RR; Vadlamudi RK
    Cancer Res; 2008 Jun; 68(12):4902-9. PubMed ID: 18559538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of ER-Src axis in hormonal therapy resistance.
    Vallabhaneni S; Nair BC; Cortez V; Challa R; Chakravarty D; Tekmal RR; Vadlamudi RK
    Breast Cancer Res Treat; 2011 Nov; 130(2):377-85. PubMed ID: 21184269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
    Landen CN; Chavez-Reyes A; Bucana C; Schmandt R; Deavers MT; Lopez-Berestein G; Sood AK
    Cancer Res; 2005 Aug; 65(15):6910-8. PubMed ID: 16061675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma.
    Nassar KM; Yang X; Baker A; Gopalam R; Arnold WC; Adeniran TT; Hernandez Fernandez MH; Mahajan M; Lai Z; Chen Y; Sareddy GR; Viswanadhapalli S; Sun LZ; Vadlamudi RK; Pratap UP
    Cancer Res Commun; 2024 Oct; 4(10):2610-2620. PubMed ID: 39258975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PELP1 suppression inhibits colorectal cancer through c-Src downregulation.
    Ning Z; Zhang Y; Chen H; Wu J; Song T; Wu Q; Liu F
    Oxid Med Cell Longev; 2014; 2014():193523. PubMed ID: 24967003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.
    Landen CN; Merritt WM; Mangala LS; Sanguino AM; Bucana C; Lu C; Lin YG; Han LY; Kamat AA; Schmandt R; Coleman RL; Gershenson DM; Lopez-Berestein G; Sood AK
    Cancer Biol Ther; 2006 Dec; 5(12):1708-13. PubMed ID: 17106249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.
    Luo Y; Li M; Pratap UP; Viswanadhapalli S; Liu J; Venkata PP; Altwegg KA; Palacios BE; Li X; Chen Y; Rao MK; Brenner AJ; Sareddy GR; Vadlamudi RK
    Mol Carcinog; 2020 Mar; 59(3):281-292. PubMed ID: 31872914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PELP1 oncogenic functions involve CARM1 regulation.
    Mann M; Cortez V; Vadlamudi R
    Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
    Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
    Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells.
    Pan Y; Wang X; Zhang Y; Qiao J; Sasano H; McNamara K; Zhao B; Zhang D; Fan Y; Liu L; Jia X; Liu M; Song S; Wang L
    Horm Cancer; 2020 Apr; 11(2):87-96. PubMed ID: 32037484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.